//error/error/500/error/404-testpage/error/404/real-world-efficacy/scalp-psoriasis/metabolic-syndrome-risk-factors/safety/patient-subgroups/dosing/mechanism-of-action/access-and-support/access-and-support/patient-access/access-and-support/obtaining-ilumya/access-and-support/access-resources/resources/connect-with-us/site-map/contact-us/covid/copay/popup-component/early-access-program-terms-and-conditions/patient-assistance-program-terms-and-conditions/1_5_Years_Safety/results/results/high-impact-areas/results/efficacy/results/patient-profiles